HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsPricing
Theme 		Help

NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

GLSI

Greenwich LifeSciences Inc

Last Close
Jul 03 • 03:12PM ET
10.03
Dollar change
+0.15
Percentage change
1.52 		%
Healthcare • Biotechnology • USA • NASD
Peers: JNJ LLY MRNA AZN PFE REGN GSK BMY BNTX NVAX
 | Held by: IWM VTI VXF IWO VTWO IWC VTWG RSSL UWM VTHR
Scroll to Statements
IndexRUT P/E- EPS (ttm)-1.26 Insider Own55.20% Shs Outstand13.19M Perf Week12.32%
Market Cap134.08M Forward P/E- EPS next Y- Insider Trans0.39% Shs Float5.99M Perf Month5.03%
Enterprise Value131.33M PEG- EPS next Q-0.24 Inst Own9.56% Short Float16.17% Perf Quarter7.27%
Income-16.57M P/S- EPS this Y22.31% Inst Trans-1.32% Short Ratio13.23 Perf Half Y-8.07%
Sales0.00M P/B100.83 EPS next Y- ROA-401.24% Short Interest0.97M Perf YTD-10.69%
Book/sh0.10 P/C48.76 EPS next 5Y- ROE-515.27% 52W High17.49 -42.65% Perf Year-40.19%
Cash/sh0.21 P/FCF- EPS past 3/5Y-50.90% -32.98% ROIC-1262.96% 52W Low8.06 24.44% Perf 3Y9.62%
Dividend Est.- EV/EBITDA- Sales past 3/5Y- - Gross Margin- Volatility5.90% 3.74% Perf 5Y-
Dividend TTM- EV/Sales- EPS Y/Y TTM-75.76% Oper. Margin- ATR (14)0.42 Perf 10Y-
Dividend Ex-Date- Quick Ratio1.91 Sales Y/Y TTM- Profit Margin- RSI (14)63.80 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio1.91 EPS Q/Q-28.65% SMA208.26% Beta3.15 Target Price39.00
Payout- Debt/Eq0.00 Sales Q/Q- SMA504.54% Rel Volume0.43 Prev Close9.88
Employees8 LT Debt/Eq0.00 EarningsMay 19 SMA200-15.14% Avg Volume73.20K Price10.03
IPOSep 25, 2020 Option/ShortNo / Yes EPS/Sales Surpr.0.00% - Trades Volume31,423 Change1.52%
Date Action Analyst Rating Change Price Target Change
Sep-01-21Initiated H.C. Wainwright Buy $78
Apr-03-25 08:00AM
Greenwich LifeSciences Provides Global Update on FLAMINGO-01
(GlobeNewswire)
Apr-02-25 06:00AM
Greenwich LifeSciences Announces Positive Immune Response Data from FLAMINGO-01 Phase III Clinical Trial
(GlobeNewswire)
Mar-27-25 06:00AM
Greenwich LifeSciences Extends Lock-up of Directors and Officers to March 31, 2026
(GlobeNewswire)
Mar-17-25 06:45AM
Greenwich LifeSciences Provides Update on Open Label Safety Data from FLAMINGO-01
(GlobeNewswire)
Feb-10-25 06:00AM
Greenwich LifeSciences Provides Update on Open Label HLA Data from FLAMINGO-01
(GlobeNewswire)
11:13AM Loading…
Jan-30-25 11:13AM
EMA approves addition of sites to Greenwich LifeSciences breast cancer trial
(Clinical Trials Arena)
Jan-29-25 06:00AM
Greenwich LifeSciences Approved to Add Additional Sites to FLAMINGO-01 in Europe
(GlobeNewswire)
Jan-27-25 06:00AM
Greenwich LifeSciences Announces Activation of Flamingo-01 in Poland
(GlobeNewswire)
Jan-23-25 06:00AM
Greenwich LifeSciences Announces Additions of Harvard and Johns Hopkins to Flamingo-01
(GlobeNewswire)
Jan-22-25 06:00AM
Greenwich LifeSciences Provides Update on Commercial Manufacturing
(GlobeNewswire)
Jan-14-25 06:15AM
Greenwich LifeSciences Announces Partnership with GBG in Germany for Flamingo-01
(GlobeNewswire)
Jan-13-25 07:00AM
Greenwich LifeSciences Partners with Unicancer Expanding Flamingo-01 into France
(GlobeNewswire)
Nov-26-24 06:00AM
Greenwich LifeSciences Partners with GIM in Italy
(GlobeNewswire)
Nov-18-24 06:00AM
Greenwich LifeSciences Provides Update on Corporate Events
(GlobeNewswire)
Aug-01-24 06:00AM
Greenwich LifeSciences Provides Update on Expansion of Flamingo-01 into Spain
(GlobeNewswire)
07:33AM Loading…
Jun-26-24 07:33AM
Greenwich LifeSciences Set to Join Russell 2000 Index Again
(GlobeNewswire) +11.18%
Jun-17-24 09:00AM
Insider Buying: CEO and CFO Snehal Patel Acquires Shares of Greenwich LifeSciences Inc (GLSI)
(GuruFocus.com) +18.16%
Jun-14-24 06:00AM
Greenwich LifeSciences Announces $2.5 Million Private Placement
(GlobeNewswire)
May-20-24 09:53PM
GLSI Stock Earnings: Greenwich LifeSciences Beats EPS for Q1 2024
(InvestorPlace) -6.44%
Apr-15-24 10:53PM
GLSI Stock Earnings: Greenwich LifeSciences Misses EPS for Q4 2023
(InvestorPlace) -8.88%
Apr-10-24 03:30PM
Insiders are Piling into These 10 Healthcare Stocks in 2024
(Insider Monkey)
Mar-13-24 06:00AM
Greenwich LifeSciences Extends Lock-up of Directors and Officers to June 30, 2025
(GlobeNewswire)
Mar-12-24 06:00AM
Greenwich LifeSciences Partners with GEICAM in Spain & Conducts First Site Initiation Visits in Europe
(GlobeNewswire) +8.20%
Mar-07-24 09:00AM
Greenwich LifeSciences Inc (GLSI) CEO and CFO, 10% Owner Snehal Patel Acquires Additional Shares
(GuruFocus.com) +19.93%
Feb-27-24 06:00AM
Greenwich LifeSciences Flamingo-01 Phase III Clinical Trial Approved to Expand into Five Largest European Countries
(GlobeNewswire)
Feb-22-24 06:00AM
Greenwich LifeSciences Flamingo-01 Manufacturing & Protocol Accepted by European Regulators
(GlobeNewswire)
Feb-14-24 06:00AM
Greenwich LifeSciences Provides Update on Phase III Clinical Trial, Flamingo-01
(GlobeNewswire) +22.74%
Nov-21-23 06:00AM
Greenwich LifeSciences Extends Lock-up of Directors and Officers to End of 2024
(GlobeNewswire)
Sep-13-23 05:02PM
Insider Buying: Snehal Patel Acquires 1,000 Shares of Greenwich LifeSciences Inc
(GuruFocus.com)
Jul-26-23 01:12PM
Daily Vickers Top Buyers & Sellers for 07/26/2023
(Argus Research)
06:53AM Loading…
Jul-18-23 06:53AM
Daily Vickers Top Buyers & Sellers for 07/18/2023
(Argus Research)
May-10-23 06:32AM
Daily Vickers Top Insider Picks for 05/10/2023
(Argus Research)
May-09-23 06:40AM
Daily Vickers Top Insider Picks for 05/09/2023
(Argus Research)
May-08-23 06:41AM
Daily Vickers Top Insider Picks for 05/08/2023
(Argus Research)
May-05-23 06:58AM
Daily Vickers Top Insider Picks for 05/05/2023
(Argus Research)
May-04-23 06:29AM
Daily Vickers Top Insider Picks for 05/04/2023
(Argus Research)
May-03-23 06:46AM
Daily Vickers Top Insider Picks for 05/03/2023
(Argus Research) +5.02%
May-02-23 06:46AM
Daily Vickers Top Insider Picks for 05/02/2023
(Argus Research)
May-01-23 06:45AM
Daily Vickers Top Insider Picks for 05/01/2023
(Argus Research) +5.88%
Apr-28-23 07:04AM
Daily Vickers Top Insider Picks for 04/28/2023
(Argus Research)
Apr-27-23 06:47AM
Daily Vickers Top Insider Picks for 04/27/2023
(Argus Research)
Apr-26-23 06:26AM
Daily Vickers Top Insider Picks for 04/26/2023
(Argus Research)
Apr-20-23 07:03AM
Daily Vickers Top Insider Picks for 04/20/2023
(Argus Research)
Apr-19-23 06:53AM
Daily Vickers Top Insider Picks for 04/19/2023
(Argus Research)
Apr-17-23 06:54AM
Daily Vickers Top Insider Picks for 04/17/2023
(Argus Research)
Apr-14-23 06:37AM
Daily Vickers Top Insider Picks for 04/14/2023
(Argus Research)
Apr-13-23 06:52AM
Daily Vickers Top Insider Picks for 04/13/2023
(Argus Research)
Apr-12-23 07:07AM
Daily Vickers Top Insider Picks for 04/12/2023
(Argus Research) -5.41%
Apr-11-23 06:58AM
Daily Vickers Top Insider Picks for 04/11/2023
(Argus Research)
Apr-10-23 06:44AM
Daily Vickers Top Insider Picks for 04/10/2023
(Argus Research)
Apr-07-23 07:44AM
Daily Vickers Top Insider Picks for 04/07/2023
(Argus Research)
Apr-06-23 10:37AM
Insiders own 39% of Greenwich LifeSciences, Inc. (NASDAQ:GLSI) shares but retail investors control 42% of the company
(Simply Wall St.)
07:20AM
Daily Vickers Top Insider Picks for 04/06/2023
(Argus Research)
Apr-05-23 06:11AM
Daily Vickers Top Insider Picks for 04/05/2023
(Argus Research)
Apr-04-23 07:08AM
Daily Vickers Top Insider Picks for 04/04/2023
(Argus Research)
Apr-03-23 06:48AM
Daily Vickers Top Insider Picks for 04/03/2023
(Argus Research)
Mar-31-23 06:36AM
Daily Vickers Top Insider Picks for 03/31/2023
(Argus Research)
Mar-30-23 06:36AM
Daily Vickers Top Insider Picks for 03/30/2023
(Argus Research)
Mar-29-23 06:32AM
Daily Vickers Top Insider Picks for 03/29/2023
(Argus Research) +8.37%
Mar-28-23 06:46AM
Daily Vickers Top Insider Picks for 03/28/2023
(Argus Research) -5.86%
Mar-24-23 06:42AM
Daily Vickers Top Insider Picks for 03/24/2023
(Argus Research)
Mar-23-23 07:01AM
Daily Vickers Top Insider Picks for 03/23/2023
(Argus Research)
Mar-21-23 06:23AM
Daily Vickers Top Insider Picks for 03/21/2023
(Argus Research) +9.36%
Mar-20-23 06:35AM
Daily Vickers Top Insider Picks for 03/20/2023
(Argus Research)
Mar-17-23 06:47AM
Daily Vickers Top Insider Picks for 03/17/2023
(Argus Research)
Mar-16-23 06:51AM
Daily Vickers Top Insider Picks for 03/16/2023
(Argus Research)
Mar-15-23 06:44AM
Daily Vickers Top Insider Picks for 03/15/2023
(Argus Research)
Mar-13-23 06:32AM
Daily Vickers Top Insider Picks for 03/13/2023
(Argus Research) +8.00%
Mar-10-23 07:04AM
Daily Vickers Top Insider Picks for 03/10/2023
(Argus Research) -6.05%
Mar-09-23 06:33AM
Daily Vickers Top Insider Picks for 03/09/2023
(Argus Research) -5.43%
Mar-08-23 06:30AM
Daily Vickers Top Insider Picks for 03/08/2023
(Argus Research)
Mar-07-23 06:34AM
Daily Vickers Top Insider Picks for 03/07/2023
(Argus Research) -5.65%
Mar-06-23 07:22AM
Daily Vickers Top Insider Picks for 03/06/2023
(Argus Research)
Mar-03-23 06:38AM
Daily Vickers Top Insider Picks for 03/03/2023
(Argus Research)
Mar-02-23 06:44AM
Daily Vickers Top Insider Picks for 03/02/2023
(Argus Research) -6.81%
Mar-01-23 06:01AM
Daily Vickers Top Insider Picks for 03/01/2023
(Argus Research)
Feb-28-23 06:43AM
Daily Vickers Top Insider Picks for 02/28/2023
(Argus Research)
Feb-27-23 06:50AM
Daily Vickers Top Insider Picks for 02/27/2023
(Argus Research)
Feb-24-23 07:17AM
Daily Vickers Top Insider Picks for 02/24/2023
(Argus Research) -7.28%
Feb-23-23 07:21AM
Daily Vickers Top Insider Picks for 02/23/2023
(Argus Research)
Feb-22-23 06:56AM
Daily Vickers Top Insider Picks for 02/22/2023
(Argus Research) +5.03%
Feb-21-23 07:35AM
Daily Vickers Top Insider Picks for 02/21/2023
(Argus Research) -8.76%
Feb-17-23 06:27AM
Daily Vickers Top Insider Picks for 02/17/2023
(Argus Research)
Feb-16-23 07:28AM
Daily Vickers Top Insider Picks for 02/16/2023
(Argus Research)
Feb-15-23 07:01AM
Daily Vickers Top Insider Picks for 02/15/2023
(Argus Research)
Feb-14-23 06:23AM
Daily Vickers Top Insider Picks for 02/14/2023
(Argus Research)
Feb-13-23 07:30AM
Daily Vickers Top Insider Picks for 02/13/2023
(Argus Research) -6.58%
Feb-10-23 06:42AM
Daily Vickers Top Insider Picks for 02/10/2023
(Argus Research)
Feb-09-23 06:51AM
Daily Vickers Top Insider Picks for 02/09/2023
(Argus Research)
Feb-08-23 06:45AM
Daily Vickers Top Insider Picks for 02/08/2023
(Argus Research)
Feb-07-23 06:46AM
Daily Vickers Top Insider Picks for 02/07/2023
(Argus Research)
Feb-06-23 06:56AM
Daily Vickers Top Insider Picks for 02/06/2023
(Argus Research)
Feb-03-23 06:32AM
Daily Vickers Top Insider Picks for 02/03/2023
(Argus Research)
Feb-02-23 06:43AM
Daily Vickers Top Insider Picks for 02/02/2023
(Argus Research)
Feb-01-23 06:14AM
Daily Vickers Top Insider Picks for 02/01/2023
(Argus Research)
05:30AM
Companies Like Greenwich LifeSciences (NASDAQ:GLSI) Are In A Position To Invest In Growth
(Simply Wall St.)
Jan-31-23 06:50AM
Daily Vickers Top Insider Picks for 01/31/2023
(Argus Research)
Jan-30-23 06:42AM
Daily Vickers Top Insider Picks for 01/30/2023
(Argus Research)
Jan-27-23 07:00AM
Daily Vickers Top Insider Picks for 01/27/2023
(Argus Research)
Jan-26-23 06:44AM
Daily Vickers Top Insider Picks for 01/26/2023
(Argus Research)
Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Patel SnehalCEO and CFOApr 25 '25Buy9.883,60035,5685,570,602Apr 29 06:14 AM
Patel SnehalCEO and CFOApr 17 '25Buy8.985,40048,4925,567,002Apr 22 06:05 AM
Patel SnehalCEO and CFOApr 07 '25Buy9.103,60032,7605,561,602Apr 08 06:05 AM
Patel SnehalCEO and CFOApr 04 '25Buy8.735,50048,0155,558,002Apr 07 07:50 AM
Patel SnehalCEO and CFOJan 10 '25Buy12.512,50031,2755,552,502Jan 13 06:05 AM
Patel SnehalCEO and CFOJan 07 '25Buy13.751,80024,7505,550,002Jan 08 06:10 AM
Patel SnehalCEO and CFOJan 06 '25Buy13.311,10014,6415,548,202Jan 08 06:10 AM
Patel SnehalCEO and CFOJan 03 '25Buy12.953,40044,0305,547,102Jan 07 06:05 AM
Patel SnehalCEO and CFOJan 02 '25Buy11.972,00023,9405,543,702Jan 06 06:05 AM
Patel SnehalCEO and CFODec 31 '24Buy11.362,40027,2645,541,702Jan 03 06:05 AM
Patel SnehalCEO and CFODec 30 '24Buy11.123,20035,5845,539,302Jan 02 06:05 AM
Thompson JayeVP Clinical Reg AffairsNov 21 '24Buy12.911,00012,910264,148Nov 25 06:03 AM
Patel SnehalCEO and CFOSep 26 '24Buy14.631,50021,9455,536,102Sep 30 06:04 AM
Thompson JayeVP Clinical Reg AffairsAug 12 '24Buy13.8580011,080263,148Sep 16 06:05 AM
Patel SnehalCEO and CFOAug 06 '24Buy13.812,00027,6205,534,602Aug 08 06:05 AM
Patel SnehalCEO and CFOAug 05 '24Buy13.185,50072,4905,532,602Aug 07 06:05 AM
Thompson JayeVP Clinical Reg AffairsAug 02 '24Buy15.151,00015,150262,348Aug 05 06:05 AM
Patel SnehalCEO and CFOJul 23 '24Buy15.891,50023,8355,527,102Jul 24 06:05 AM
Thompson JayeVP Clinical Reg AffairsJul 18 '24Buy16.001,00016,000261,348Jul 22 06:05 AM
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
Affiliate • Advertise • Theme Settings • Contact • Help • Privacy • Do Not Sell My Personal Information
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2025 FINVIZ.com. All Rights Reserved.